Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 ...

All three RSV vaccines -- GSK's Arexvy, Pfizer's Abrysvo ... Branche reported relationships with Pfizer, Moderna, Merck, ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...

Read the Market Summary Here @- India Animal Vaccine Market Size Zooming 3.6X at Healthy CAGR of More Than 7% to Surpass USD 4.87 Billion and 376.1 Million Doses by 2030 India Animal Vaccine Market ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...

Earlier in his career, he held senior leadership positions at Merck KGaA. CureVac sees significant opportunities to apply precision immunotherapy using mRNA vaccines in large patient populations. The ...